Related Experiment Video
Updated: May 22, 2026

07:24
A Method for Quantifying Upper Limb Performance in Daily Life Using Accelerometers
Published on: April 21, 2017
Capturing ambulatory activity decline in Parkinson's disease
James T Cavanaugh1, Terry D Ellis, Gammon M Earhart
1Department of Physical Therapy, University of New England, Portland, ME, USA. jcavanaugh@une.edu
Journal of Neurologic Physical Therapy : JNPT
|May 18, 2012
Summary
Parkinson's disease (PD) patients show declines in daily walking amount and intensity over one year, even without changes in clinical measures. Continuous monitoring reveals subtle ambulatory behavior changes.
Area of Science:
- Neurology
- Gerontology
- Rehabilitation Medicine
Background:
- The natural progression of physical activity limitations in Parkinson's disease (PD) is not well understood.
- Continuous monitoring technology offers a novel approach to assess free-living ambulatory activity in individuals with PD.
Purpose of the Study:
- To prospectively investigate long-term changes in daily ambulatory activity in persons with PD.
- To compare the sensitivity of ambulatory activity parameters with clinical gait and disease severity measures.
Main Methods:
- Thirty-three individuals with PD (Hoehn and Yahr 1-3) wore step activity monitors for 7 days at baseline and 1-year follow-up.
- Ambulatory activity parameters (amount, intensity, frequency, duration) were calculated. Clinical measures included UPDRS, 6-Minute Walk, and Gait Speed.
- Paired sample tests analyzed changes in ambulatory activity and clinical measures.
Main Results:
- Significant decreases in the amount and intensity of daily ambulatory activity were observed over one year (P < 0.007).
- No significant changes were noted in the frequency or duration of ambulatory activity.
- The most substantial decline was in daily minutes of moderate-intensity ambulatory activity, despite stable clinical measures.
Conclusions:
- Continuous monitoring of ambulatory activity provides a unique metric for tracking functional decline or improvement in Parkinson's disease.
- This method may offer a more sensitive indicator of disease progression or treatment effects than traditional clinical assessments.
Related Concept Videos
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

